生物類似藥（Biosimilar）是指在質量、安全性和有效性方面與已獲準注冊的參照藥具有相似性的治療用生物制品，包括單抗、重組蛋白、 血液制品等。
吉滿生物擁有一百多種Biosimilar抗體，可供客戶選擇。
生物類似藥（Biosimilar）是指在質量、安全性和有效性方面與已獲準注冊的參照藥具有相似性的治療用生物制品，包括單抗、重組蛋白、 血液制品等。
吉滿生物擁有一百多種Biosimilar抗體，可供客戶選擇。
常見單抗案例
Anti-PD1 hlgG4 Antibody（Pembrolizumab）
羊駝抗體案例
Anti-CDH17 hlgG1 Antibody （VHHl-28BB）
雙抗案例
Anti-CTLA-4 PD-1 hlgG1 Bispecific Antibody（Cadonilimab）
| 分類 | 靶點 | 產品編號 | 產品名稱 |
GPCR
|
CALCA(CGRP)：CALCRL RAMP
|
GM-51996AB
|
Anti-CALCRL RAMP1 hIgG2 Antibody(Erenumab)
|
|
GPCR
|
CCL1:CCR8
|
GM-28205AB
|
Anti-Mouse_CCR8 mIgG2a Antibody
|
|
GPCR
|
CCL1:CCR8
|
GM-47423AB
|
Anti-Cynomolgus_CCR8 hIgG1 Antibody
|
|
GPCR
|
CCL1:CCR8
|
GM-53822AB
|
Anti-H_CCR8 hIgG1 Antibody(Defucosylated,BMS-986340)
|
|
GPCR
|
CCR4
|
GM-23370AB
|
Anti-H_CCR4 hIgG1 Antibody(Mogamulizumab)
|
|
GPCR
|
CNR1(CB1)
|
GM-47472AB
|
Anti-H_CB1 hIgG4 Antibody(Nimacimab)
|
|
GPCR
|
FSHR
|
GM-50111AB
|
Anti-FSHR hIgG1 Antibody(9H11)
|
|
GPCR
|
GCGR
|
GM-84555AB
|
Anti-H_GCGR hIgG2 Antibody(volagidemab)
|
|
GPCR
|
GIP:GIPR
|
GM-84915AB
|
Anti-H_GIPR hIgG1 Antibody（AMG-133）
|
|
GPCR
|
GLP1R
|
GM-51168AB
|
Anti-GLP1R hIgG1 Antibody(mAb-36986)
|
|
GPCR
|
GLP1R
|
GM-84914AB
|
Anti-H_GLP1R hIgG1 Antibody（glutazumab）
|
|
GPCR
|
GPRC5D
|
GM-31061AB
|
Anti-H_GPRC5D hIgG4 Antibody(Talquetamab)
|
|
GPCR
|
LGR5
|
GM-46303AB
|
Anti-H_LGR5 hIgG1 Antibody(18G7H6A3)
|
|
Kinase
|
C-MET:HGF
|
GM-28859AB
|
Anti-H_HGFR(Met) hIgG4 Antibody(Emibetuzumab)
|
|
Kinase
|
EGF:EGFR:ADAM17
|
GM-49155AB
|
Anti-H_EGFR hIgG1 Antibody(Necitumumab)
|
|
Kinase
|
HER2(ERBB2)
|
GM-49468AB
|
Anti-H_HER2 hIgG1 Antibody(Margetuximab)
|
|
Kinase
|
HER2(ERBB2)
|
GM-87130MAB
|
Anti-Her2 hIgG1 Reference Antibody(Marbio)
|
|
Kinase
|
HER2(ERBB2)
|
GM-87131MAB
|
Anti-Her2 hIgG1 Reference Antibody(Trasbio)
|
|
Kinase
|
HER3(ERBB3)
|
GM-28858AB
|
Anti-H_ERBB3(HER3) hIgG1 Antibody(Barecetamab)
|
|
Kinase
|
HER3(ERBB3)
|
GM-87129MAB
|
Anti-ERBB3(HER3) hIgG1 Reference Antibody(Patribio)
|
|
Kinase
|
INSR:insulin
|
GM-27376AB
|
Anti-H_INSR hIgG1 Antibody(Valanafusp)
|
|
Kinase
|
INSR:insulin
|
GM-51390AB
|
Anti-INSR hIgG1 Antibody(XPA.15.247.2.018)
|
|
TAA
|
ALPPL2 ALPP
|
GM-58773AB
|
Anti-ALPPL2 mIgG2a antibody(SGN-ALPV)
|
|
TAA
|
ALPPL2 ALPP
|
GM-58774AB
|
Anti-ALPPL2 hIgG1 antibody(SGN-ALPV)
|
|
TAA
|
ALPPL2 ALPP
|
GM-86291 MAB
|
Anti-H_ALPPL2 hIgG1 Reference Antibody（h12F3）
|
|
TAA
|
AMHR2
|
GM-27802AB
|
Anti-AMHR2 hIgG1 Antibody(Murlentamab)
|
|
TAA
|
BCMA:BAFFR:TACI
|
GM-49476AB
|
Anti-BCMA hIgG4 Antibody(BCMB69)
|
|
TAA
|
BCMA:BAFFR:TACI
|
GM-49486AB
|
Anti-BCMA hIgG1 Antibody(SEA-BCMA)
|
|
TAA
|
BCMA:BAFFR:TACI
|
GM-52396AB
|
Anti-BCMA hIgG1 Antibody(Belantamab)
|
|
TAA
|
CA9(CAIX)
|
GM-27130AB
|
Anti-H_CAIX hIgG1 Antibody(girentuximab)
|
|
TAA
|
CD19
|
GM-28777AB
|
Anti-H_CD19 hIgG1/hIgG2 Antibody(Tafasitamab)
|
|
TAA
|
CD2
|
GM-79929AB
|
Anti-CD2 hIgG1 Antibody（BTI-322）
|
|
TAA
|
CD22(IGLEC2)
|
GM-31561AB
|
Anti-H_CD22 hIgG1 Antibody(Pinatuzumab)
|
|
TAA
|
CD38
|
GM-27202AB
|
Anti-CD38 hIgG1 Antibody(Daratumumab)
|
|
TAA
|
CD4
|
GM-28752AB
|
Anti-H_CD4 hIgG1 Antibody(Tregalizumab)
|
|
TAA
|
CD71(TFRC)
|
GM-30129AB
|
Anti-H_TFRC(CD71) hIgG1 Antibody(Pabinafusp)
|
|
TAA
|
CD79
|
GM-28857AB
|
Anti-H_CD79B hIgG1 Antibody(Iladatuzumab)
|
|
TAA
|
CDH17
|
GM-52672AB
|
Anti-CDH17 hIgG1 Antibody(BI-905711)
|
|
TAA
|
CDH17
|
GM-75321AB
|
Anti-CDH17 hIgG1 Antibody(VHHl-28BB)
|
|
TAA
|
CDH3
|
GM-46573AB
|
Anti-H_CDH3 hIgG1 Antibody
|
|
TAA
|
CDH6
|
GM-46607AB
|
Anti-H_CDH6 hIgG1 Antibody(H01L02)
|
|
TAA
|
CEACAM5
|
GM-28531AB
|
Anti-CEA hIgG1 Antibody(Cibisatamab)
|
|
TAA
|
CEACAM6
|
GM-30166AB
|
Anti-H_CEACAM6(CD66c) hIgG1 Antibody(Tinurilimab)
|
|
TAA
|
CEACAM7
|
GM-51007AB
|
Anti-CEACAM7 hIgG4 Antibody(2869)
|
|
TAA
|
CLDN18
|
GM-34137AB
|
Anti-CLDN18.2 hIgG1 Antibody(Zolbetuximab)
|
|
TAA
|
CLDN6
|
GM-49724AB
|
Anti-CLDN6/9 hIgG1 Antibody
|
|
TAA
|
CLEC12A(CLL1)
|
GM-52592AB
|
Anti-CLEC12A hIgG1 Antibody（H6e7）
|
|
TAA
|
DDR1;DDR2
|
GM-46777AB
|
Anti-H_DDR1 hIgG1 Antibody
|
|
TAA
|
DLL3
|
GM-26560AB
|
Anti-H_DLL3 hIgG1 Antibody(Rovalpituzumab)
|
|
TAA
|
F3(CD142)
|
GM-28928AB
|
Anti-H_F3(CD142) hIgG1 Antibody(Tisotumab)
|
|
TAA
|
FAP
|
GM-30156AB
|
Anti-H_FAP hIgG1 Antibody(Simlukafusp)
|
|
TAA
|
FOLH1(PSMA)
|
GM-27353AB
|
Anti-FOLH1(PSMA) hIgG1 Antibody(Rosopatamab)
|
|
TAA
|
FOLR1(FRα)
|
GM-27354AB
|
Anti-FOLR1 hIgG1 Antibody(Mirvetuximab)
|
|
TAA
|
FOLR1(FRα)
|
GM-86372MAB
|
Anti-FOLR1 hIgG1 Reference Antibody(Mirvebio)
|
|
TAA
|
GPA33
|
GM-50417AB
|
Anti-H_GPA33 hIgG1 Antibody(A2)
|
|
TAA
|
GPA33
|
GM-52271AB
|
Anti-GPA33 hIgG1 Antibody(DART-2)
|
|
TAA
|
GPC3
|
GM-28751AB
|
Anti-GPC3 hIgG1 Antibody(Codrituzumab)
|
|
TAA
|
GUCY2C
|
GM-28860AB
|
Anti-H_GUCY2C hIgG1 Antibody(Indusatumab)
|
|
TAA
|
IL3:CD123(IL3RA)
|
GM-27123AB
|
Anti-H_CD123 hIgG2 Antibody(Talacotuzumab)
|
|
TAA
|
LY6E
|
GM-31757AB
|
Anti-H_LY6E hIgG1 Antibody(Hu9B12v12)
|
|
TAA
|
LY6G6D
|
GM-58917AB
|
Anti-LY6G6D hIgG1 Antibody(20A12 .QNTv12)
|
|
TAA
|
MSLN
|
GM-24027AB
|
Anti-H_MSLN hIgG1 Antibody(Amatuximab)
|
|
TAA
|
NECTIN4
|
GM-23369AB
|
Anti-H_Nectin4 hIgG1 Antibody(Enfortumab)
|
|
TAA
|
Notch DLL4
|
GM-51815AB
|
Anti-DLL4 hIgG2 Antibody(Navicixizumab)
|
|
TAA
|
Notch DLL4
|
GM-51820AB
|
Anti-DLL4 hIgG1 Antibody(MLCK-2(ABL-001))
|
|
TAA
|
PTK7
|
GM-56186AB
|
Anti-PTK7 hIgG1 Antibody(Cofetuzumab)
|
|
TAA
|
Sialyl-Tn (STN) MUC1
|
GM-28930AB
|
Anti-H_MUC1(CD227)hIgG1 Antibody(Clivatuzumab)
|
|
TAA
|
SLC34A2
|
GM-26828AB
|
Anti-SLC34A2 hIgG1 Antibody(XMT-1536)
|
|
TAA
|
SLC39A6（LIV1）
|
GM-26839AB
|
Anti-H_SLC39A6 hIgG1 Antibody(Ladiratuzumab)
|
|
TAA
|
SSTR2
|
GM-59883AB
|
Anti-SSTR2 hIgG1 Antibody(XENP018087)
|
|
TAA
|
STEAP1
|
GM-33026AB
|
Anti-H_STEAP1 hIgG1 Antibody(Vandortuzumab)
|
|
TAA
|
TM4SF1
|
GM-59881AB
|
Anti-TM4SF1 hIgG1 Antibody(hAGX-A07H2L5)
|
|
TAA
|
TM4SF1
|
GM-59885AB
|
Anti-TM4SF1 hIgG1 Antibody(hAGX-A01H1L10)
|
|
TAA
|
TNFRSF8(CD30)
|
GM-28856AB
|
Anti-H_TNFRSF8(CD30) hIgG1 Antibody（Brentuximab）
|
|
TAA
|
TROP2(TACSTD2)
|
GM-26561AB
|
Anti-H_TROP2 hIgG1 Antibody(Datopotamab)
|
|
TAA
|
TSPAN8
|
GM-82623AB
|
Anti-TSPAN8 mIgG2b Antibody(Ts29.2)
|
|
TAA
|
TSPAN8
|
GM-82624AB
|
Anti-TSPAN8 hIgG1 Antibody(16B11)
|
|
TGF-beta
|
ACVR2A：ACTRIIB：Active A
|
GM-51148AB
|
Anti-ACVR2B hIgG1 Antibody(Bimagrumab)
|
|
TGF-beta
|
ACVR2A：ACTRIIB：Active A
|
GM-82350AB
|
Anti-ACVR2B hIgG1 Antibody(Fab-17G05)
|
|
TGF-beta
|
ACVR2A：ACTRIIB：Active A
|
GM-86367MAB
|
?Anti-H_ACVR2B hIgG1 Reference Antibody(Bimbio)
|
|
TGF-beta
|
TGF-β:GARP:avβ6
|
GM-26831AB
|
Anti-TGFB1 hIgG4 Antibody(SRK-181)
|
|
TGF-beta
|
TGF-β:GARP:avβ6
|
GM-30474AB
|
Anti-GARP-TGF-β1 hIgG4 Antibody(ARGX-115)
|
|
TGF-beta
|
TGF-β:GARP:avβ6
|
GM-49298AB
|
Anti-αv hIgG2 Antibody(Abituzumab)
|
|
TGF-beta
|
TGF-β:GARP:avβ6
|
GM-53193AB
|
Anti-αvβ6 hIgG1 Antibody(m15H3)
|
|
TGF-beta
|
TGF-β:GARP:avβ6
|
GM-81622AB
|
Anti-ITGB6 hIgG1 Antibody(SGN-B6A)
|
|
TNF家族
|
DR5(TNFRSF10B)
|
GM-50886AB
|
Anti-TNFRSF10B(DR5) hIgG1 Antibody(drozitumab)
|
|
TNF家族
|
DR5(TNFRSF10B)
|
GM-50887AB
|
Anti-H_TNFRSF10B(DR5) hIgG1 Antibody(Conatumumab)
|
|
TNF家族
|
TL1A:DR3(TNFRSF25)
|
GM-30140AB
|
Anti-H_TNFSF15(TL1A) hIgG4 Antibody
|
|
TNF家族
|
TL1A:DR3(TNFRSF25)
|
GM-58913AB
|
Anti-TNFRSF25(DR3) hIgG1 Antibody(PTX-35)
|
|
TNF家族
|
TL1A:DR3(TNFRSF25)
|
GM-58915AB
|
Anti-H_TNFSF15(TL1A) hIgG1 Antibody(Tulisokibart、PRA-023)
|
|
TNF家族
|
TL1A:DR3(TNFRSF25)
|
GM-59479AB
|
Anti-H_TNFSF15(TL1A) hIgG1 Antibody(PF-06480605)
|
|
TNF家族
|
TNF:TNFR2:TNFR1
|
GM-49245AB
|
Anti-H_TNFRSF1B(TNFR2) hIgG1 Antibody(UC2.3.8)
|
|
Wnt
|
ROR1
|
GM-48031AB
|
Anti-ROR1 hIgG1 Antibody(Zilovertamab/Cirmtuzumab)
|
|
Wnt
|
TPBG(5T4)
|
GM-52191AB
|
Anti-5T4 hIgG1 Antibody(825c)
|
|
抗體相關
|
FcγR
|
GM-37413AB
|
Anti-H_FcRn IgG4 Antibody(Rozanolixizumab)
|
|
免疫
|
BDCA2(CLEC4C)
|
GM-31294AB
|
Anti-H_BDCA2 hIgG1 Antibody(Litifilimab)
|
|
免疫
|
BTN3:Vγ9Vδ2
|
GM-52820AB
|
Anti-BTN2A1 mIgG1 Antibody（mAb 7.48）
|
|
免疫
|
BTN3:Vγ9Vδ2
|
GM-52829AB
|
Anti-H_BTN3A1 hIgG1 Antibody(hu103.2)
|
|
免疫
|
BTN3:Vγ9Vδ2
|
GM-52838AB
|
Anti-BTN3A1 hIgG1 Antibody（mAb1）
|
|
免疫
|
BTN3:Vγ9Vδ2
|
GM-75325AB
|
Anti-Vγ9Vδ2 TCR hIgG1 Antibody
|
|
免疫
|
CD20(MS4A1)
|
GM-27200AB
|
Anti-H_MS4A1(CD20) hIgG1 Antibody(Ocrelizumab)
|
|
免疫
|
CD3
|
GM-33037AB
|
Anti-CD3 hIgG1 Antibody(CH2527)
|
|
免疫
|
CD3
|
GM-51478AB
|
Anti-CD3 epsilon hIgG1 Antibody [OKT-3 (muromonab)]
|
|
免疫
|
CD73(NT5E)
|
GM-28674AB
|
Anti-H_NT5E(CD73) hIgG1 Antibody(Oleclumab)
|
|
免疫
|
HLA-G
|
GM-28208AB
|
Anti-H_HLA-G1 hIgG1 Antibody(38373)
|
|
免疫
|
LILRA4(ILT7)
|
GM-32190AB
|
Anti-LILRA4 hIgG1 Antibody（Daxdilimab）
|
|
免疫
|
LILRB1(ILT2)
|
GM-27366AB
|
Anti-LILRB1(ILT2) mIgG1 Antibody(12D12)
|
|
免疫
|
LILRB1(ILT2)
|
GM-47134AB
|
Anti-LILRB1/LILRB2 hIgG1 Antibody
|
|
免疫
|
LILRB2(ILT4)
|
GM-27362AB
|
Anti-H_LILRB2(ILT4) hIgG4 Antibody(MK-4830)
|
|
免疫
|
LILRB3(ILT5)
|
GM-27367AB
|
Anti-LILRB3 hIgG1 Antibody(7C5)
|
|
免疫
|
MICA;MICB
|
GM-48843AB
|
Anti-MICA/MICB hIgG1 Antibody(36 NF G236A)
|
|
免疫
|
MICA;MICB
|
GM-51336AB
|
Anti-MICA/MICB mIgG2a Antibody(7C6)
|
|
免疫
|
MICA;MICB
|
GM-52540AB
|
Anti-MICA/MICB mIgG2a Antibody(PDI-01)
|
|
免疫
|
NKG2A:HLA-E
|
GM-34467AB
|
Anti-H_KLRC1 hIgG4 Antibody(Monalizumab)
|
|
免疫
|
NKG2A:HLA-E
|
GM-49158AB
|
Anti-HLA-E hIgG1 Antibody(ABX-0020)
|
|
免疫
|
NKG2D
|
GM-28955AB
|
Anti-H_KLRK1(NKG2D) hIgG4 Antibody(Tesnatilimab)
|
|
免疫
|
NKG2D
|
GM-52535AB
|
Anti-NKG2D hIgG1 Antibody(A49MI)
|
|
免疫
|
NKP30:B7-H6
|
GM-49311AB
|
Anti-NKP30 hIgG1 Antibody(BGA-1833)
|
|
免疫
|
NKp46
|
GM-29003AB
|
Anti-NCR1(NKP46) hIgG1 Antibody
|
|
免疫
|
SIGLEC3(CD33)
|
GM-28754AB
|
Anti-H_CD33(siglec3) hIgG4 Antibody(Gemtuzumab)
|
|
免疫
|
TSLP:TSLPR
|
GM-31018AB
|
Anti-H_TSLPR hIgG1 Antibody
|
|
免疫檢查點
|
4-1BB
|
GM-26840AB
|
Anti-H_4-1BB hIgG2 Antibody(Utomilumab)
|
|
免疫檢查點
|
4-1BB
|
GM-28954AB
|
Anti-H_TNFRSF9(4-1BB) hIgG4 Antibody(Urelumab)
|
|
免疫檢查點
|
BTLA:HVEM:LIGHT
|
GM-28675AB
|
Anti-BTLA hIgG4 Antibody(Icatolimab)
|
|
免疫檢查點
|
BTLA:HVEM:LIGHT
|
GM-30127AB
|
Anti-TNFSF14 hIgG4 Antibody
|
|
免疫檢查點
|
BTLA:HVEM:LIGHT
|
GM-49928AB
|
Anti-TNFRSF14(HVEM) hIgG4 Antibody
|
|
免疫檢查點
|
BTLA:HVEM:LIGHT
|
GM-50103AB
|
Anti-BTLA hIgG4 Antibody(22B3)
|
|
免疫檢查點
|
CD112:CD112R(PVRIG)-CD226
|
GM-27659AB
|
Anti-H_PVRIG hIgG1 Antibody
|
|
免疫檢查點
|
CD112:CD112R(PVRIG)-CD226
|
GM-30125AB
|
Anti-H_NECTIN2(CD112) hIgG1 Antibody
|
|
免疫檢查點
|
CD112:CD112R(PVRIG)-CD226
|
GM-48167AB
|
Anti-CD112R hIgG1 Antibody(SRF813)
|
|
免疫檢查點
|
CD200 CD200R
|
GM-48237AB
|
Anti-CD200R hIgG4 Antibody(I-4P)
|
|
免疫檢查點
|
CD200 CD200R
|
GM-48240AB
|
Anti-CD200R hIgG4 Antibody
|
|
免疫檢查點
|
CD200 CD200R
|
GM-48346AB
|
Anti-H_CD200R hIgG1 Antibody(huDX182)
|
|
免疫檢查點
|
CD200 CD200R
|
GM-48495AB
|
Anti-H_CD200 hIgG Antibody(Samalizumab)
|
|
免疫檢查點
|
CD27:CD70
|
GM-24024AB
|
Anti-H_CD70 hIgG1 Antibody(Cusatuzumab)
|
|
免疫檢查點
|
CD28
|
GM-27197AB
|
Anti-H_CD28 hIgG4 Antibody(Theralizumab)
|
|
免疫檢查點
|
CD28
|
GM-52277AB
|
Anti-CD28 hIgG4 Antibody(FR104)
|
|
免疫檢查點
|
CD40：CD40L
|
GM-24025AB
|
Anti-H_CD40 hIgG1 Antibody(APX005M)
|
|
免疫檢查點
|
CD40：CD40L
|
GM-83977AB
|
Anti-H_CD40L hIgG1 Antibody(dapirolizumab)
|
|
免疫檢查點
|
CD40：CD40L
|
GM-86199AB
|
Anti-H_CD40 hIgG1 Antibody(ravagalimab)
|
|
免疫檢查點
|
CD47:SIRPα
|
GM-27657AB
|
Anti-CD47 hIgG4 Antibody(5F9)
|
|
免疫檢查點
|
CTLA4:CD80:CD86
|
GM-27203AB
|
Anti-H_CTLA-4 hIgG1 Antibody(Ipilimumab)
|
|
免疫檢查點
|
CTLA4:CD80:CD86
|
GM-46075AB
|
Anti-H_CD80 hIgG1 Antibody(Galiximab)
|
|
免疫檢查點
|
CTLA4:CD80:CD86
|
GM-60293AB
|
Anti-CTLA-4/PD-1 hIgG1 Bispecific Antibody(Cadonilimab)
|
|
免疫檢查點
|
HAVCR2(TIM3)：CEACAM1
|
GM-27128AB
|
Anti-H_HAVCR2(TIM3) hIgG4 Antibody(Sabatolimab)
|
|
免疫檢查點
|
HAVCR2(TIM3)：CEACAM1
|
GM-30164AB
|
Anti-H_CEACAM1(CD66a) hIgG4 Antibody(MK-6018)
|
|
免疫檢查點
|
HAVCR2(TIM3)：CEACAM1
|
GM-50627AB
|
Anti-TIM3 hIgG2 Antibody(M6903)
|
|
免疫檢查點
|
Lag3
|
GM-28753AB
|
Anti-H_LAG3 hIgG4 Antibody(Mavezelimab)
|
|
免疫檢查點
|
Lag3
|
GM-51647AB
|
Anti-Lag3 hIgG4 Antibody(IMP-7)
|
|
免疫檢查點
|
Lag3
|
GM-51650AB
|
Anti-Lag3 hIgG4 Antibody(Relatlimab)
|
|
免疫檢查點
|
OX40
|
GM-23373AB
|
Anti-H_OX40 hIgG2 Antibody(Ivuxolimab)
|
|
免疫檢查點
|
OX40
|
GM-82533AB
|
Anti-OX40L hIgG4 Antibody(Amlitelimab)
|
|
免疫檢查點
|
PD-1:PD-L1(B7-H1):PDL2
|
GM-28206AB
|
Anti-Mouse_PD1 mIgG1 Antibody
|
|
免疫檢查點
|
PD-1:PD-L1(B7-H1):PDL2
|
GM-28957AB
|
Anti-H_PDCD1(PD1) hIgG1 Antibody(Budigalimab)
|
|
免疫檢查點
|
PD-1:PD-L1(B7-H1):PDL2
|
GM-31740AB
|
Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab)
|
|
免疫檢查點
|
PD-1:PD-L1(B7-H1):PDL2
|
GM-32251AB
|
Anti-H_PDCD1LG2 mIgG1 Antibody(3G2)
|
|
免疫檢查點
|
PD-1:PD-L1(B7-H1):PDL2
|
GM-52674AB
|
Anti-PD1 hIgG4 Antibody(Pembrolizumab)
|
|
免疫檢查點
|
PD-1:PD-L1(B7-H1):PDL2
|
GM-79817AB
|
Anti-PD-L2 hIgG1 Antibody(Hz25G4-1.1)
|
|
免疫檢查點
|
SIGLEC15
|
GM-24717AB
|
Anti-Siglec15 mIgG2a Antibody(5G12)
|
|
免疫檢查點
|
SIGLEC8
|
GM-28730AB
|
Anti-H_SIGLEC8 hIgG1 Antibody(1H10)
|
|
免疫檢查點
|
SIGLEC9
|
GM-31414AB
|
Anti-siglec9 mIgG1 Antibody(2D4)
|
|
免疫檢查點
|
TIGIT:PVR:CD155:CD226
|
GM-24029AB
|
Anti-H_Tigit hIgG1 Antibody(Vibostolimab)
|
|
免疫檢查點
|
TREM2
|
GM-22998AB
|
Anti-H_TREM2 Rat_IgG2b Antibody
|
|
免疫檢查點
|
TREM2
|
GM-30244AB
|
Anti-TREM2 hIgG1 Antibody
|
|
免疫檢查點
|
TREM2
|
GM-48593AB
|
Anti-H_TREM2 hIgG4 Antibody
|
|
免疫檢查點
|
VTCN1(B7H4)
|
GM-24028AB
|
Anti-H_B7H4(VTCN1) hIgG1 Antibody(FPA150)
|
|
免疫檢查點
|
VTCN1(B7H4)
|
GM-86662MAB
|
Anti-H_B7H4 hIgG1 Reference Antibody(FPA150)
|
|
其他
|
MELTF(CD228)
|
GM-38396AB
|
Anti-H_MELTF(CD228) hIgG1 Antibody(hL49 HALC)
|
|
細胞因子
|
GDF15 GFRAL
|
GM-71274AB
|
Anti-H_GDF15 hIgG4 Antibody(CTL-002)
|
|
細胞因子
|
GDF15 GFRAL
|
GM-71276AB
|
Anti-H_GFRAL Antibody(QUEL-0301)
|
|
細胞因子
|
IL-1
|
GM-51764AB
|
Anti-IL-1β hIgG1 Antibody(Canakinumab)
|
|
細胞因子
|
IL-1
|
GM-51990AB
|
Anti-IL1R1 hIgG1 Antibody(AMG 108)
|
|
細胞因子
|
IL-11
|
GM-57288AB
|
Anti-IL-11 hIgG4 Antibody(Hu16E12)
|
|
細胞因子
|
IL-12
|
GM-46333AB
|
Anti-IL-12/23(p40) hIgG1 antibody(Ustekinumab)
|
|
細胞因子
|
IL-17
|
GM-27267AB
|
Anti-IL-17A hIgG1 Antibody(Secukinumab)
|
|
細胞因子
|
IL-2
|
GM-52319AB
|
Anti-CD122 hIgG1 Antibody（HuABC-2）
|
|
細胞因子
|
IL-2
|
GM-52329AB
|
Anti-CD25 hIgG1 Antibody(Basiliximab)
|
|
細胞因子
|
IL-2
|
GM-52334AB
|
Anti-CD132(IL2RG) hIgG4 Antibody(REGN7257)
|
|
細胞因子
|
IL-22
|
GM-46382AB
|
Anti-H_IL-22R1 hIgG1 Antibody(ARGX-112)
|
|
細胞因子
|
IL-22
|
GM-46509AB
|
Anti-H_IL-22 hIgG1 Antibody(Fezakinumab)
|
|
細胞因子
|
IL-31
|
GM-50871AB
|
Anti-IL31RA hIgG2 Antibody(Nemolizumab)
|
|
細胞因子
|
IL-31
|
GM-50874AB
|
Anti-OSMR hIgG4 Antibody(Vixarelimab)
|
|
細胞因子
|
IL-31
|
GM-50880AB
|
Anti-IL31RA hIgG1 Antibody(NA633)
|
|
細胞因子
|
IL-31
|
GM-50883AB
|
Anti-IL31 hIgG1 Antibody(mAb33)
|
|
細胞因子
|
IL-33
|
GM-31628AB
|
Anti-IL33 hIgG4 Antibody(Itepekimab)
|
|
細胞因子
|
IL-4/IL-13
|
GM-46268AB
|
Anti-IL-4R hIgG1 Antibody(12B5)
|
|
細胞因子
|
IL-4/IL-13
|
GM-53165AB
|
Anti-IL4R hIgG4 Antibody（Dupilumab）
|
|
細胞因子
|
IL-5
|
GM-46851AB
|
Anti-IL-5R hIgG1 Antibody(Benralizumab)
|
|
細胞因子
|
IL-5
|
GM-52408AB
|
Anti-IL5 hIgG4 Antibody(Reslizumab)
|
|
細胞因子
|
IL-7
|
GM-52274AB
|
Anti-IL7Ra hIgG1 Antibody(4A10)
|
|
細胞因子
|
PRL:PRLR
|
GM-27198AB
|
Anti-PRLR hIgG1 Antibody(Mat3)
|
|
細胞因子
|
VEGF
|
GM-51978AB
|
Anti-VEGF hIgG1 Antibody(Bevacizumab)
|
|
整合素,細胞因子
|
CTGF(CCN2):aVb3
|
GM-51031AB
|
Anti-CTGF hIgG1 Antibody(Pamrevlumab)
|
|
整合素,細胞因子
|
CTGF(CCN2):aVb3
|
GM-51125AB
|
Anti-ITGB3 hIgG1 Antibody(Etaracizumab)
|
| 分類 | 靶點 | 產品編號 | 產品名稱 |
|
GPCR
|
CALCA(CGRP)：CALCRL RAMP
|
GM-51996AB
|
Anti-CALCRL RAMP1 hIgG2 Antibody(Erenumab)
|
|
GPCR
|
CCL1:CCR8
|
GM-28205AB
|
Anti-Mouse_CCR8 mIgG2a Antibody
|
|
GPCR
|
CCL1:CCR8
|
GM-47423AB
|
Anti-Cynomolgus_CCR8 hIgG1 Antibody
|
|
GPCR
|
CCL1:CCR8
|
GM-53822AB
|
Anti-H_CCR8 hIgG1 Antibody(Defucosylated,BMS-986340)
|
|
GPCR
|
CCR4
|
GM-23370AB
|
Anti-H_CCR4 hIgG1 Antibody(Mogamulizumab)
|
|
GPCR
|
CNR1(CB1)
|
GM-47472AB
|
Anti-H_CB1 hIgG4 Antibody(Nimacimab)
|
|
GPCR
|
FSHR
|
GM-50111AB
|
Anti-FSHR hIgG1 Antibody(9H11)
|
|
GPCR
|
GCGR
|
GM-84555AB
|
Anti-H_GCGR hIgG2 Antibody(volagidemab)
|
|
GPCR
|
GIP:GIPR
|
GM-84915AB
|
Anti-H_GIPR hIgG1 Antibody（AMG-133）
|
|
GPCR
|
GLP1R
|
GM-51168AB
|
Anti-GLP1R hIgG1 Antibody(mAb-36986)
|
|
GPCR
|
GLP1R
|
GM-84914AB
|
Anti-H_GLP1R hIgG1 Antibody（glutazumab）
|
|
GPCR
|
GPRC5D
|
GM-31061AB
|
Anti-H_GPRC5D hIgG4 Antibody(Talquetamab)
|
|
GPCR
|
LGR5
|
GM-46303AB
|
Anti-H_LGR5 hIgG1 Antibody(18G7H6A3)
|
|
Kinase
|
C-MET:HGF
|
GM-28859AB
|
Anti-H_HGFR(Met) hIgG4 Antibody(Emibetuzumab)
|
|
Kinase
|
EGF:EGFR:ADAM17
|
GM-49155AB
|
Anti-H_EGFR hIgG1 Antibody(Necitumumab)
|
|
Kinase
|
HER2(ERBB2)
|
GM-49468AB
|
Anti-H_HER2 hIgG1 Antibody(Margetuximab)
|
|
Kinase
|
HER2(ERBB2)
|
GM-87130MAB
|
Anti-Her2 hIgG1 Reference Antibody(Marbio)
|
|
Kinase
|
HER2(ERBB2)
|
GM-87131MAB
|
Anti-Her2 hIgG1 Reference Antibody(Trasbio)
|
|
Kinase
|
HER3(ERBB3)
|
GM-28858AB
|
Anti-H_ERBB3(HER3) hIgG1 Antibody(Barecetamab)
|
|
Kinase
|
HER3(ERBB3)
|
GM-87129MAB
|
Anti-ERBB3(HER3) hIgG1 Reference Antibody(Patribio)
|
|
Kinase
|
INSR:insulin
|
GM-27376AB
|
Anti-H_INSR hIgG1 Antibody(Valanafusp)
|
|
Kinase
|
INSR:insulin
|
GM-51390AB
|
Anti-INSR hIgG1 Antibody(XPA.15.247.2.018)
|
|
TAA
|
ALPPL2 ALPP
|
GM-58773AB
|
Anti-ALPPL2 mIgG2a antibody(SGN-ALPV)
|
|
TAA
|
ALPPL2 ALPP
|
GM-58774AB
|
Anti-ALPPL2 hIgG1 antibody(SGN-ALPV)
|
|
TAA
|
ALPPL2 ALPP
|
GM-86291 MAB
|
Anti-H_ALPPL2 hIgG1 Reference Antibody（h12F3）
|
|
TAA
|
AMHR2
|
GM-27802AB
|
Anti-AMHR2 hIgG1 Antibody(Murlentamab)
|
|
TAA
|
BCMA:BAFFR:TACI
|
GM-49476AB
|
Anti-BCMA hIgG4 Antibody(BCMB69)
|
|
TAA
|
BCMA:BAFFR:TACI
|
GM-49486AB
|
Anti-BCMA hIgG1 Antibody(SEA-BCMA)
|
|
TAA
|
BCMA:BAFFR:TACI
|
GM-52396AB
|
Anti-BCMA hIgG1 Antibody(Belantamab)
|
|
TAA
|
CA9(CAIX)
|
GM-27130AB
|
Anti-H_CAIX hIgG1 Antibody(girentuximab)
|
|
TAA
|
CD19
|
GM-28777AB
|
Anti-H_CD19 hIgG1/hIgG2 Antibody(Tafasitamab)
|
|
TAA
|
CD2
|
GM-79929AB
|
Anti-CD2 hIgG1 Antibody（BTI-322）
|
|
TAA
|
CD22(IGLEC2)
|
GM-31561AB
|
Anti-H_CD22 hIgG1 Antibody(Pinatuzumab)
|
|
TAA
|
CD38
|
GM-27202AB
|
Anti-CD38 hIgG1 Antibody(Daratumumab)
|
|
TAA
|
CD4
|
GM-28752AB
|
Anti-H_CD4 hIgG1 Antibody(Tregalizumab)
|
|
TAA
|
CD71(TFRC)
|
GM-30129AB
|
Anti-H_TFRC(CD71) hIgG1 Antibody(Pabinafusp)
|
|
TAA
|
CD79
|
GM-28857AB
|
Anti-H_CD79B hIgG1 Antibody(Iladatuzumab)
|
|
TAA
|
CDH17
|
GM-52672AB
|
Anti-CDH17 hIgG1 Antibody(BI-905711)
|
|
TAA
|
CDH17
|
GM-75321AB
|
Anti-CDH17 hIgG1 Antibody(VHHl-28BB)
|
|
TAA
|
CDH3
|
GM-46573AB
|
Anti-H_CDH3 hIgG1 Antibody
|
|
TAA
|
CDH6
|
GM-46607AB
|
Anti-H_CDH6 hIgG1 Antibody(H01L02)
|
|
TAA
|
CEACAM5
|
GM-28531AB
|
Anti-CEA hIgG1 Antibody(Cibisatamab)
|
|
TAA
|
CEACAM6
|
GM-30166AB
|
Anti-H_CEACAM6(CD66c) hIgG1 Antibody(Tinurilimab)
|
|
TAA
|
CEACAM7
|
GM-51007AB
|
Anti-CEACAM7 hIgG4 Antibody(2869)
|
|
TAA
|
CLDN18
|
GM-34137AB
|
Anti-CLDN18.2 hIgG1 Antibody(Zolbetuximab)
|
|
TAA
|
CLDN6
|
GM-49724AB
|
Anti-CLDN6/9 hIgG1 Antibody
|
|
TAA
|
CLEC12A(CLL1)
|
GM-52592AB
|
Anti-CLEC12A hIgG1 Antibody（H6e7）
|
|
TAA
|
DDR1;DDR2
|
GM-46777AB
|
Anti-H_DDR1 hIgG1 Antibody
|
|
TAA
|
DLL3
|
GM-26560AB
|
Anti-H_DLL3 hIgG1 Antibody(Rovalpituzumab)
|
|
TAA
|
F3(CD142)
|
GM-28928AB
|
Anti-H_F3(CD142) hIgG1 Antibody(Tisotumab)
|
|
TAA
|
FAP
|
GM-30156AB
|
Anti-H_FAP hIgG1 Antibody(Simlukafusp)
|
|
TAA
|
FOLH1(PSMA)
|
GM-27353AB
|
Anti-FOLH1(PSMA) hIgG1 Antibody(Rosopatamab)
|
|
TAA
|
FOLR1(FRα)
|
GM-27354AB
|
Anti-FOLR1 hIgG1 Antibody(Mirvetuximab)
|
|
TAA
|
FOLR1(FRα)
|
GM-86372MAB
|
Anti-FOLR1 hIgG1 Reference Antibody(Mirvebio)
|
|
TAA
|
GPA33
|
GM-50417AB
|
Anti-H_GPA33 hIgG1 Antibody(A2)
|
|
TAA
|
GPA33
|
GM-52271AB
|
Anti-GPA33 hIgG1 Antibody(DART-2)
|
|
TAA
|
GPC3
|
GM-28751AB
|
Anti-GPC3 hIgG1 Antibody(Codrituzumab)
|
|
TAA
|
GUCY2C
|
GM-28860AB
|
Anti-H_GUCY2C hIgG1 Antibody(Indusatumab)
|
|
TAA
|
IL3:CD123(IL3RA)
|
GM-27123AB
|
Anti-H_CD123 hIgG2 Antibody(Talacotuzumab)
|
|
TAA
|
LY6E
|
GM-31757AB
|
Anti-H_LY6E hIgG1 Antibody(Hu9B12v12)
|
|
TAA
|
LY6G6D
|
GM-58917AB
|
Anti-LY6G6D hIgG1 Antibody(20A12 .QNTv12)
|
|
TAA
|
MSLN
|
GM-24027AB
|
Anti-H_MSLN hIgG1 Antibody(Amatuximab)
|
|
TAA
|
NECTIN4
|
GM-23369AB
|
Anti-H_Nectin4 hIgG1 Antibody(Enfortumab)
|
|
TAA
|
Notch DLL4
|
GM-51815AB
|
Anti-DLL4 hIgG2 Antibody(Navicixizumab)
|
|
TAA
|
Notch DLL4
|
GM-51820AB
|
Anti-DLL4 hIgG1 Antibody(MLCK-2(ABL-001))
|
|
TAA
|
PTK7
|
GM-56186AB
|
Anti-PTK7 hIgG1 Antibody(Cofetuzumab)
|
|
TAA
|
Sialyl-Tn (STN) MUC1
|
GM-28930AB
|
Anti-H_MUC1(CD227)hIgG1 Antibody(Clivatuzumab)
|
|
TAA
|
SLC34A2
|
GM-26828AB
|
Anti-SLC34A2 hIgG1 Antibody(XMT-1536)
|
|
TAA
|
SLC39A6（LIV1）
|
GM-26839AB
|
Anti-H_SLC39A6 hIgG1 Antibody(Ladiratuzumab)
|
|
TAA
|
SSTR2
|
GM-59883AB
|
Anti-SSTR2 hIgG1 Antibody(XENP018087)
|
|
TAA
|
STEAP1
|
GM-33026AB
|
Anti-H_STEAP1 hIgG1 Antibody(Vandortuzumab)
|
|
TAA
|
TM4SF1
|
GM-59881AB
|
Anti-TM4SF1 hIgG1 Antibody(hAGX-A07H2L5)
|
|
TAA
|
TM4SF1
|
GM-59885AB
|
Anti-TM4SF1 hIgG1 Antibody(hAGX-A01H1L10)
|
|
TAA
|
TNFRSF8(CD30)
|
GM-28856AB
|
Anti-H_TNFRSF8(CD30) hIgG1 Antibody（Brentuximab）
|
|
TAA
|
TROP2(TACSTD2)
|
GM-26561AB
|
Anti-H_TROP2 hIgG1 Antibody(Datopotamab)
|
|
TAA
|
TSPAN8
|
GM-82623AB
|
Anti-TSPAN8 mIgG2b Antibody(Ts29.2)
|
|
TAA
|
TSPAN8
|
GM-82624AB
|
Anti-TSPAN8 hIgG1 Antibody(16B11)
|
|
TGF-beta
|
ACVR2A：ACTRIIB：Active A
|
GM-51148AB
|
Anti-ACVR2B hIgG1 Antibody(Bimagrumab)
|
|
TGF-beta
|
ACVR2A：ACTRIIB：Active A
|
GM-82350AB
|
Anti-ACVR2B hIgG1 Antibody(Fab-17G05)
|
|
TGF-beta
|
ACVR2A：ACTRIIB：Active A
|
GM-86367MAB
|
?Anti-H_ACVR2B hIgG1 Reference Antibody(Bimbio)
|
|
TGF-beta
|
TGF-β:GARP:avβ6
|
GM-26831AB
|
Anti-TGFB1 hIgG4 Antibody(SRK-181)
|
|
TGF-beta
|
TGF-β:GARP:avβ6
|
GM-30474AB
|
Anti-GARP-TGF-β1 hIgG4 Antibody(ARGX-115)
|
|
TGF-beta
|
TGF-β:GARP:avβ6
|
GM-49298AB
|
Anti-αv hIgG2 Antibody(Abituzumab)
|
|
TGF-beta
|
TGF-β:GARP:avβ6
|
GM-53193AB
|
Anti-αvβ6 hIgG1 Antibody(m15H3)
|
|
TGF-beta
|
TGF-β:GARP:avβ6
|
GM-81622AB
|
Anti-ITGB6 hIgG1 Antibody(SGN-B6A)
|
|
TNF家族
|
DR5(TNFRSF10B)
|
GM-50886AB
|
Anti-TNFRSF10B(DR5) hIgG1 Antibody(drozitumab)
|
|
TNF家族
|
DR5(TNFRSF10B)
|
GM-50887AB
|
Anti-H_TNFRSF10B(DR5) hIgG1 Antibody(Conatumumab)
|
|
TNF家族
|
TL1A:DR3(TNFRSF25)
|
GM-30140AB
|
Anti-H_TNFSF15(TL1A) hIgG4 Antibody
|
|
TNF家族
|
TL1A:DR3(TNFRSF25)
|
GM-58913AB
|
Anti-TNFRSF25(DR3) hIgG1 Antibody(PTX-35)
|
|
TNF家族
|
TL1A:DR3(TNFRSF25)
|
GM-58915AB
|
Anti-H_TNFSF15(TL1A) hIgG1 Antibody(Tulisokibart、PRA-023)
|
|
TNF家族
|
TL1A:DR3(TNFRSF25)
|
GM-59479AB
|
Anti-H_TNFSF15(TL1A) hIgG1 Antibody(PF-06480605)
|
|
TNF家族
|
TNF:TNFR2:TNFR1
|
GM-49245AB
|
Anti-H_TNFRSF1B(TNFR2) hIgG1 Antibody(UC2.3.8)
|
|
Wnt
|
ROR1
|
GM-48031AB
|
Anti-ROR1 hIgG1 Antibody(Zilovertamab/Cirmtuzumab)
|
|
Wnt
|
TPBG(5T4)
|
GM-52191AB
|
Anti-5T4 hIgG1 Antibody(825c)
|
|
抗體相關
|
FcγR
|
GM-37413AB
|
Anti-H_FcRn IgG4 Antibody(Rozanolixizumab)
|
|
免疫
|
BDCA2(CLEC4C)
|
GM-31294AB
|
Anti-H_BDCA2 hIgG1 Antibody(Litifilimab)
|
|
免疫
|
BTN3:Vγ9Vδ2
|
GM-52820AB
|
Anti-BTN2A1 mIgG1 Antibody（mAb 7.48）
|
|
免疫
|
BTN3:Vγ9Vδ2
|
GM-52829AB
|
Anti-H_BTN3A1 hIgG1 Antibody(hu103.2)
|
|
免疫
|
BTN3:Vγ9Vδ2
|
GM-52838AB
|
Anti-BTN3A1 hIgG1 Antibody（mAb1）
|
|
免疫
|
BTN3:Vγ9Vδ2
|
GM-75325AB
|
Anti-Vγ9Vδ2 TCR hIgG1 Antibody
|
|
免疫
|
CD20(MS4A1)
|
GM-27200AB
|
Anti-H_MS4A1(CD20) hIgG1 Antibody(Ocrelizumab)
|
|
免疫
|
CD3
|
GM-33037AB
|
Anti-CD3 hIgG1 Antibody(CH2527)
|
|
免疫
|
CD3
|
GM-51478AB
|
Anti-CD3 epsilon hIgG1 Antibody [OKT-3 (muromonab)]
|
|
免疫
|
CD73(NT5E)
|
GM-28674AB
|
Anti-H_NT5E(CD73) hIgG1 Antibody(Oleclumab)
|
|
免疫
|
HLA-G
|
GM-28208AB
|
Anti-H_HLA-G1 hIgG1 Antibody(38373)
|
|
免疫
|
LILRA4(ILT7)
|
GM-32190AB
|
Anti-LILRA4 hIgG1 Antibody（Daxdilimab）
|
|
免疫
|
LILRB1(ILT2)
|
GM-27366AB
|
Anti-LILRB1(ILT2) mIgG1 Antibody(12D12)
|
|
免疫
|
LILRB1(ILT2)
|
GM-47134AB
|
Anti-LILRB1/LILRB2 hIgG1 Antibody
|
|
免疫
|
LILRB2(ILT4)
|
GM-27362AB
|
Anti-H_LILRB2(ILT4) hIgG4 Antibody(MK-4830)
|
|
免疫
|
LILRB3(ILT5)
|
GM-27367AB
|
Anti-LILRB3 hIgG1 Antibody(7C5)
|
|
免疫
|
MICA;MICB
|
GM-48843AB
|
Anti-MICA/MICB hIgG1 Antibody(36 NF G236A)
|
|
免疫
|
MICA;MICB
|
GM-51336AB
|
Anti-MICA/MICB mIgG2a Antibody(7C6)
|
|
免疫
|
MICA;MICB
|
GM-52540AB
|
Anti-MICA/MICB mIgG2a Antibody(PDI-01)
|
|
免疫
|
NKG2A:HLA-E
|
GM-34467AB
|
Anti-H_KLRC1 hIgG4 Antibody(Monalizumab)
|
|
免疫
|
NKG2A:HLA-E
|
GM-49158AB
|
Anti-HLA-E hIgG1 Antibody(ABX-0020)
|
|
免疫
|
NKG2D
|
GM-28955AB
|
Anti-H_KLRK1(NKG2D) hIgG4 Antibody(Tesnatilimab)
|
|
免疫
|
NKG2D
|
GM-52535AB
|
Anti-NKG2D hIgG1 Antibody(A49MI)
|
|
免疫
|
NKP30:B7-H6
|
GM-49311AB
|
Anti-NKP30 hIgG1 Antibody(BGA-1833)
|
|
免疫
|
NKp46
|
GM-29003AB
|
Anti-NCR1(NKP46) hIgG1 Antibody
|
|
免疫
|
SIGLEC3(CD33)
|
GM-28754AB
|
Anti-H_CD33(siglec3) hIgG4 Antibody(Gemtuzumab)
|
|
免疫
|
TSLP:TSLPR
|
GM-31018AB
|
Anti-H_TSLPR hIgG1 Antibody
|
|
免疫檢查點
|
4-1BB
|
GM-26840AB
|
Anti-H_4-1BB hIgG2 Antibody(Utomilumab)
|
|
免疫檢查點
|
4-1BB
|
GM-28954AB
|
Anti-H_TNFRSF9(4-1BB) hIgG4 Antibody(Urelumab)
|
|
免疫檢查點
|
BTLA:HVEM:LIGHT
|
GM-28675AB
|
Anti-BTLA hIgG4 Antibody(Icatolimab)
|
|
免疫檢查點
|
BTLA:HVEM:LIGHT
|
GM-30127AB
|
Anti-TNFSF14 hIgG4 Antibody
|
|
免疫檢查點
|
BTLA:HVEM:LIGHT
|
GM-49928AB
|
Anti-TNFRSF14(HVEM) hIgG4 Antibody
|
|
免疫檢查點
|
BTLA:HVEM:LIGHT
|
GM-50103AB
|
Anti-BTLA hIgG4 Antibody(22B3)
|
|
免疫檢查點
|
CD112:CD112R(PVRIG)-CD226
|
GM-27659AB
|
Anti-H_PVRIG hIgG1 Antibody
|
|
免疫檢查點
|
CD112:CD112R(PVRIG)-CD226
|
GM-30125AB
|
Anti-H_NECTIN2(CD112) hIgG1 Antibody
|
|
免疫檢查點
|
CD112:CD112R(PVRIG)-CD226
|
GM-48167AB
|
Anti-CD112R hIgG1 Antibody(SRF813)
|
|
免疫檢查點
|
CD200 CD200R
|
GM-48237AB
|
Anti-CD200R hIgG4 Antibody(I-4P)
|
|
免疫檢查點
|
CD200 CD200R
|
GM-48240AB
|
Anti-CD200R hIgG4 Antibody
|
|
免疫檢查點
|
CD200 CD200R
|
GM-48346AB
|
Anti-H_CD200R hIgG1 Antibody(huDX182)
|
|
免疫檢查點
|
CD200 CD200R
|
GM-48495AB
|
Anti-H_CD200 hIgG Antibody(Samalizumab)
|
|
免疫檢查點
|
CD27:CD70
|
GM-24024AB
|
Anti-H_CD70 hIgG1 Antibody(Cusatuzumab)
|
|
免疫檢查點
|
CD28
|
GM-27197AB
|
Anti-H_CD28 hIgG4 Antibody(Theralizumab)
|
|
免疫檢查點
|
CD28
|
GM-52277AB
|
Anti-CD28 hIgG4 Antibody(FR104)
|
|
免疫檢查點
|
CD40：CD40L
|
GM-24025AB
|
Anti-H_CD40 hIgG1 Antibody(APX005M)
|
|
免疫檢查點
|
CD40：CD40L
|
GM-83977AB
|
Anti-H_CD40L hIgG1 Antibody(dapirolizumab)
|
|
免疫檢查點
|
CD40：CD40L
|
GM-86199AB
|
Anti-H_CD40 hIgG1 Antibody(ravagalimab)
|
|
免疫檢查點
|
CD47:SIRPα
|
GM-27657AB
|
Anti-CD47 hIgG4 Antibody(5F9)
|
|
免疫檢查點
|
CTLA4:CD80:CD86
|
GM-27203AB
|
Anti-H_CTLA-4 hIgG1 Antibody(Ipilimumab)
|
|
免疫檢查點
|
CTLA4:CD80:CD86
|
GM-46075AB
|
Anti-H_CD80 hIgG1 Antibody(Galiximab)
|
|
免疫檢查點
|
CTLA4:CD80:CD86
|
GM-60293AB
|
Anti-CTLA-4/PD-1 hIgG1 Bispecific Antibody(Cadonilimab)
|
|
免疫檢查點
|
HAVCR2(TIM3)：CEACAM1
|
GM-27128AB
|
Anti-H_HAVCR2(TIM3) hIgG4 Antibody(Sabatolimab)
|
|
免疫檢查點
|
HAVCR2(TIM3)：CEACAM1
|
GM-30164AB
|
Anti-H_CEACAM1(CD66a) hIgG4 Antibody(MK-6018)
|
|
免疫檢查點
|
HAVCR2(TIM3)：CEACAM1
|
GM-50627AB
|
Anti-TIM3 hIgG2 Antibody(M6903)
|
|
免疫檢查點
|
Lag3
|
GM-28753AB
|
Anti-H_LAG3 hIgG4 Antibody(Mavezelimab)
|
|
免疫檢查點
|
Lag3
|
GM-51647AB
|
Anti-Lag3 hIgG4 Antibody(IMP-7)
|
|
免疫檢查點
|
Lag3
|
GM-51650AB
|
Anti-Lag3 hIgG4 Antibody(Relatlimab)
|
|
免疫檢查點
|
OX40
|
GM-23373AB
|
Anti-H_OX40 hIgG2 Antibody(Ivuxolimab)
|
|
免疫檢查點
|
OX40
|
GM-82533AB
|
Anti-OX40L hIgG4 Antibody(Amlitelimab)
|
|
免疫檢查點
|
PD-1:PD-L1(B7-H1):PDL2
|
GM-28206AB
|
Anti-Mouse_PD1 mIgG1 Antibody
|
|
免疫檢查點
|
PD-1:PD-L1(B7-H1):PDL2
|
GM-28957AB
|
Anti-H_PDCD1(PD1) hIgG1 Antibody(Budigalimab)
|
|
免疫檢查點
|
PD-1:PD-L1(B7-H1):PDL2
|
GM-31740AB
|
Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab)
|
|
免疫檢查點
|
PD-1:PD-L1(B7-H1):PDL2
|
GM-32251AB
|
Anti-H_PDCD1LG2 mIgG1 Antibody(3G2)
|
|
免疫檢查點
|
PD-1:PD-L1(B7-H1):PDL2
|
GM-52674AB
|
Anti-PD1 hIgG4 Antibody(Pembrolizumab)
|
|
免疫檢查點
|
PD-1:PD-L1(B7-H1):PDL2
|
GM-79817AB
|
Anti-PD-L2 hIgG1 Antibody(Hz25G4-1.1)
|
|
免疫檢查點
|
SIGLEC15
|
GM-24717AB
|
Anti-Siglec15 mIgG2a Antibody(5G12)
|
|
免疫檢查點
|
SIGLEC8
|
GM-28730AB
|
Anti-H_SIGLEC8 hIgG1 Antibody(1H10)
|
|
免疫檢查點
|
SIGLEC9
|
GM-31414AB
|
Anti-siglec9 mIgG1 Antibody(2D4)
|
|
免疫檢查點
|
TIGIT:PVR:CD155:CD226
|
GM-24029AB
|
Anti-H_Tigit hIgG1 Antibody(Vibostolimab)
|
|
免疫檢查點
|
TREM2
|
GM-22998AB
|
Anti-H_TREM2 Rat_IgG2b Antibody
|
|
免疫檢查點
|
TREM2
|
GM-30244AB
|
Anti-TREM2 hIgG1 Antibody
|
|
免疫檢查點
|
TREM2
|
GM-48593AB
|
Anti-H_TREM2 hIgG4 Antibody
|
|
免疫檢查點
|
VTCN1(B7H4)
|
GM-24028AB
|
Anti-H_B7H4(VTCN1) hIgG1 Antibody(FPA150)
|
|
免疫檢查點
|
VTCN1(B7H4)
|
GM-86662MAB
|
Anti-H_B7H4 hIgG1 Reference Antibody(FPA150)
|
|
其他
|
MELTF(CD228)
|
GM-38396AB
|
Anti-H_MELTF(CD228) hIgG1 Antibody(hL49 HALC)
|
|
細胞因子
|
GDF15 GFRAL
|
GM-71274AB
|
Anti-H_GDF15 hIgG4 Antibody(CTL-002)
|
|
細胞因子
|
GDF15 GFRAL
|
GM-71276AB
|
Anti-H_GFRAL Antibody(QUEL-0301)
|
|
細胞因子
|
IL-1
|
GM-51764AB
|
Anti-IL-1β hIgG1 Antibody(Canakinumab)
|
|
細胞因子
|
IL-1
|
GM-51990AB
|
Anti-IL1R1 hIgG1 Antibody(AMG 108)
|
|
細胞因子
|
IL-11
|
GM-57288AB
|
Anti-IL-11 hIgG4 Antibody(Hu16E12)
|
|
細胞因子
|
IL-12
|
GM-46333AB
|
Anti-IL-12/23(p40) hIgG1 antibody(Ustekinumab)
|
|
細胞因子
|
IL-17
|
GM-27267AB
|
Anti-IL-17A hIgG1 Antibody(Secukinumab)
|
|
細胞因子
|
IL-2
|
GM-52319AB
|
Anti-CD122 hIgG1 Antibody（HuABC-2）
|
|
細胞因子
|
IL-2
|
GM-52329AB
|
Anti-CD25 hIgG1 Antibody(Basiliximab)
|
|
細胞因子
|
IL-2
|
GM-52334AB
|
Anti-CD132(IL2RG) hIgG4 Antibody(REGN7257)
|
|
細胞因子
|
IL-22
|
GM-46382AB
|
Anti-H_IL-22R1 hIgG1 Antibody(ARGX-112)
|
|
細胞因子
|
IL-22
|
GM-46509AB
|
Anti-H_IL-22 hIgG1 Antibody(Fezakinumab)
|
|
細胞因子
|
IL-31
|
GM-50871AB
|
Anti-IL31RA hIgG2 Antibody(Nemolizumab)
|
|
細胞因子
|
IL-31
|
GM-50874AB
|
Anti-OSMR hIgG4 Antibody(Vixarelimab)
|
|
細胞因子
|
IL-31
|
GM-50880AB
|
Anti-IL31RA hIgG1 Antibody(NA633)
|
|
細胞因子
|
IL-31
|
GM-50883AB
|
Anti-IL31 hIgG1 Antibody(mAb33)
|
|
細胞因子
|
IL-33
|
GM-31628AB
|
Anti-IL33 hIgG4 Antibody(Itepekimab)
|
|
細胞因子
|
IL-4/IL-13
|
GM-46268AB
|
Anti-IL-4R hIgG1 Antibody(12B5)
|
|
細胞因子
|
IL-4/IL-13
|
GM-53165AB
|
Anti-IL4R hIgG4 Antibody（Dupilumab）
|
|
細胞因子
|
IL-5
|
GM-46851AB
|
Anti-IL-5R hIgG1 Antibody(Benralizumab)
|
|
細胞因子
|
IL-5
|
GM-52408AB
|
Anti-IL5 hIgG4 Antibody(Reslizumab)
|
|
細胞因子
|
IL-7
|
GM-52274AB
|
Anti-IL7Ra hIgG1 Antibody(4A10)
|
|
細胞因子
|
PRL:PRLR
|
GM-27198AB
|
Anti-PRLR hIgG1 Antibody(Mat3)
|
|
細胞因子
|
VEGF
|
GM-51978AB
|
Anti-VEGF hIgG1 Antibody(Bevacizumab)
|
|
整合素,細胞因子
|
CTGF(CCN2):aVb3
|
GM-51031AB
|
Anti-CTGF hIgG1 Antibody(Pamrevlumab)
|
|
整合素,細胞因子
|
CTGF(CCN2):aVb3
|
GM-51125AB
|
Anti-ITGB3 hIgG1 Antibody(Etaracizumab)
|
生物類似藥（Biosimilar）是指在質量、安全性和有效性方面與已獲準注冊的參照藥具有相似性的治療用生物制品，包括單抗、重組蛋白、 血液制品等。
吉滿生物擁有一百多種Biosimilar抗體，可供客戶選擇。
常見單抗案例
Anti-PD1 hlgG4 Antibody（Pembrolizumab）
羊駝抗體案例
Anti-CDH17 hlgG1 Antibody （VHHl-28BB）
雙抗案例
Anti-CTLA-4 PD-1 hlgG1 Bispecific Antibody（Cadonilimab）
